In this report, Argaam highlights the expected results of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) in Q4 2023, in addition to the development in quarterly earnings, as well as performance and profitability indicators.
&nb
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
